Evidence map›Paper›PMID 20534854›Full record

ArticleJournal of virology2010

CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.

Peter Dias, Francesca Giannoni, Lian Ni Lee, Dongun Han, Sorah Yoon, Hideo Yagita, Miyuki Azuma, Sally R Sarawar

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Peter DiasTorrey Pines Institute for Molecular Studies, 3550 General Atomics Court, San Diego, California 92121, USA.
Francesca Giannoni
Lian Ni Lee
Dongun Han
Sorah Yoon
Hideo Yagita
Miyuki Azuma
Sally R Sarawar
General Atomics (United States) · USTorrey Pines Institute For Molecular Studies · USJuntendo University · JPTokyo Medical and Dental University · JP

Funding

Immunological control of a persistent viral infectionR01AI050810 · NIAID · TORREY PINES INST FOR MOLECULAR STUDIES · PI SARAWAR, SALLY R. · 2003 to 2010
$2.7M
Gene expression in non-functional CD8 T cellsR21AI057599 · NIAID · TORREY PINES INST FOR MOLECULAR STUDIES · PI SARAWAR, SALLY R. · 2004 to 2005
$526k
Immunological control of a persistent viral infectionR21AI050810 · NIAID · LA JOLLA INST FOR ALLERGY &IMMUNOLGY · PI SARAWAR, SALLY R. · 2002 to 2002
$416k
NIAID NIH HHS AI050810NIAID NIH HHS AI057599NIAID NIH HHS R01 AI050810NIAID NIH HHS R21 AI050810NIAID NIH HHS R21 AI057599
6 · The paper itself

Abstract

We previously showed that agonistic antibodies to CD40 could substitute for CD4 T-cell help and prevent reactivation of murine gammaherpesvirus 68 (MHV-68) in the lungs of major histocompatibility complex (MHC) class II(-/-) (CII(-/-)) mice, which are CD4 T cell deficient. Although CD8 T cells were required for this effect, no change in their activity was detected in vitro. A key question was whether anti-CD40 treatment (or CD4 T-cell help) changed the function of CD8 T cells or another cell type in vivo. To address this question, in the present study, we showed that adoptive transfer of CD8 T cells from virus-infected wild-type mice or anti-CD40-treated CII(-/-) mice caused a significant reduction in lung viral titers, in contrast to those from control CII(-/-) mice. Anti-CD40 treatment also greatly prolonged survival of infected CII(-/-) mice. This confirms that costimulatory signals cause a change in CD8 T cells enabling them to maintain effective long-term control of MHV-68. We investigated the nature of this change and found that expression of the inhibitory receptor PD-1 was significantly increased on CD8 T cells in the lungs of MHV-68-infected CII(-/-), CD40(-/-), or CD80/86(-/-) mice, compared with that in wild-type or CD28/CTLA4(-/-) mice, correlating with the level of viral reactivation. Furthermore, blocking PD-1-PD-L1 interactions significantly reduced viral reactivation in CD4 T-cell-deficient mice. In contrast, the absence of another inhibitory receptor, NKG2A, had no effect. These data suggest that CD4 T-cell help programs a change in CD8 T-cell function mediated by altered PD-1 expression, which enables effective long-term control of MHV-68.

Indexed as

Adoptive TransferAnimalsAntigens, DifferentiationB7-1 AntigenB7-H1 AntigenCD40 AntigensCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleHistocompatibility Antigens Class IILungMembrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutPeptidesAntigens, DifferentiationB7-1 AntigenB7-H1 AntigenCd274 protein, mouseCD40 AntigensHistocompatibility Antigens Class IIMembrane GlycoproteinsPdcd1 protein, mousePeptidesProgrammed Cell Death 1 Receptor

Identifiers

PMID20534854
PMCPMC2916546
OpenAlexW2021454859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.